基本信息
浏览量:8
职业迁徙
个人简介
Trials in extremely premature babies are challenging, and Dr Tarnow-Mordi and team are working to form global partnerships with clinicians, with the aim of finding cost-effective treatments that will reduce infant mortality and illness. The CTC’s Neonatal Research program focuses on areas of need, e.g. neonatal infection, oxygen therapy and simple cost-effective measures to reduce health problems and improve outcomes for high-risk newborn infants. His work has helped to improve survival rates in very preterm infants, influence clinical practice and achieve major health care cost savings worldwide by identifying ineffective treatments. Professor Tarnow-Mordi serves on the Steering Group of NSW Health’s Better Treatment for Kids Network and is co-chair of the Perinatal Society of Australia and New Zealand Clinical Trials Working Group.
研究兴趣
论文共 99 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Georg M. Schmölzer,Elizabeth V. Asztalos,Marc Beltempo, Hector Boix,Eugene Dempsey,Walid El-Naggar,Neil N. Finer, Jo-Anna Hudson,Amit Mukerji, Brenda H. Y. Law,Maryna Yaskina,Prakesh S. Shah,
Trialsno. 1 (2024): 1-13
Research Square (Research Square) (2022)
The Lancet Child & Adolescent Healthno. 3 (2022): 150-157
LANCET CHILD & ADOLESCENT HEALTHno. 3 (2022): E12-E12
The Lancet Child & Adolescent Healthno. 3 (2022): 150-157
引用18浏览0引用
18
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn